Singapore develops tailored AI model for local healthcare needs

Singapore is advancing its healthcare capabilities with the development of a national artificial intelligence (AI) model, SIMFONI, designed to meet the specific needs of its population. This initiative, led by the Consortium for Clinical Research and Innovation, initially targets cardiometabolic conditions, such as diabetes and hypertension, and various eye diseases, including cataracts and glaucoma.

The SIMFONI model will be trained using Singapore's own clinical data and adheres to local guidelines. This localized approach is critical, as the country's healthcare system faces mounting challenges, including an aging demographic, a rising prevalence of chronic diseases, and a strained workforce. The ultimate goal is to integrate these AI tools seamlessly into the nation's electronic medical records system.

A key driver for SIMFONI is the recognized limitation of many existing AI foundation models in healthcare. These are predominantly trained on data from Western populations, which may not accurately reflect the health profiles and clinical presentations found in Singapore. By using local data, SIMFONI aims to enhance diagnostic accuracy and improve treatment management for Singaporean patients.

Health Minister Ong Ye Kung announced the initiative, highlighting its potential to bolster the healthcare system's resilience and effectiveness. The consortium, established in 2025, is focusing on developing clinical decision support tools for primary care and multimodal AI models for ophthalmology, addressing significant chronic disease burdens within the nation's primary care sector.

“

The AI models would be trained using clinical data and local guidelines.